目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 BIOLOGICS SAFETY TESTING MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 30)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARIES: BIOLOGICS SAFETY TESTING MARKET
2.1.3 MARKET DATA ESTIMATION AND TRIANGULATION
2.1.4 DATA TRIANGULATION
FIGURE 4 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: SEGMENTAL ANALYSIS-BASED ESTIMATION
FIGURE 7 BIOLOGICS SAFETY TESTING MARKET: FINAL CAGR PROJECTIONS (2021−2026)
FIGURE 8 BIOLOGICS SAFETY TESTING: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 9 BIOLOGICS SAFETY TESTING MARKET: SEGMENTAL ASSESSMENT
2.3 INDUSTRY INSIGHTS
2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 39)
FIGURE 10 BIOLOGICS SAFETY TESTING MARKET SHARE, BY PRODUCT & SERVICE, 2020
FIGURE 11 BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE BIOLOGICS SAFETY TESTING MARKET

4 PREMIUM INSIGHTS (Page No. - 42)
4.1 BIOLOGICS SAFETY TESTING MARKET OVERVIEW
FIGURE 14 GROWTH IN THE BIOLOGICS AND BIOSIMILARS MARKETS TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION AND COUNTRY (2020)
FIGURE 15 MONOCLONAL ANTIBODIES MANUFACTURING SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020
4.3 BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE
FIGURE 16 RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 45)
5.1 MARKET DYNAMICS
FIGURE 17 BIOLOGICS SAFETY TESTING MARKET: DRIVERS,OPPORTUNITIES, & CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Growth in the biosimilars and biologics markets
FIGURE 18 TOTAL NUMBER OF NEW BIOLOGICS LICENSE APPLICATION APPROVALS, NDA APPROVALS, AND FILINGS (2005-2019)
TABLE 1 LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS IN THE US, 2019
5.1.1.2 Growing concerns over cell culture contamination
5.1.1.3 Rising biopharmaceuticals R&D activities and investments
FIGURE 19 R&D SPENDING BY PHRMA MEMBER COMPANIES,2001-2019 (USD BILLION)
TABLE 2 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2019 VS. 2026 (USD BILLION)
5.1.2 OPPORTUNITIES
5.1.2.1 Emerging markets offer lucrative opportunities
5.1.2.2 Increasing biopharmaceutical outsourcing
5.1.3 CHALLENGES
5.1.3.1 Dearth of skilled professionals
5.2 IMPACT OF COVID-19 ON THE BIOLOGICS SAFETY TESTING MARKET
5.3 PRICING ANALYSIS
TABLE 3 AVERAGE SELLING PRICE OF BIOLOGICS SAFETY TESTING PRODUCTS (2020)
5.4 VALUE CHAIN ANALYSIS
FIGURE 20 VALUE CHAIN ANALYSIS OF THE BIOLOGICS SAFETY TESTING MARKET
5.5 ECOSYSTEM ANALYSIS OF THE BIOLOGICS SAFETY TESTING MARKET
FIGURE 21 ECOSYSTEM ANALYSIS OF THE BIOLOGICS SAFETY TESTING MARKET
5.6 PATENT ANALYSIS
FIGURE 22 NUMBER OF PATENTS GRANTED IN THE LAST 20 YEARS
TABLE 4 TOP 10 GRANTED PATENT OWNERS (US) IN THE LAST 20 YEARS
FIGURE 23 TOP 10 PLAYERS WITH THE HIGHEST NUMBER OF PATENT APPLICATIONS
5.7 REGULATORY ANALYSIS
5.7.1 US
5.7.2 EUROPE
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY

6 BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE (Page No. - 58)
6.1 INTRODUCTION
TABLE 6 BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
6.2 SERVICES
6.2.1 INCREASING OUTSOURCING OF BIOLOGICS SAFETY TESTING BY PHARMA & BIOPHARMA COMPANIES TO DRIVE THE MARKET GROWTH
TABLE 7 BIOLOGICS SAFETY TESTING SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 8 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET,BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 9 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 10 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.3 CONSUMABLES
6.3.1 REPEAT PURCHASE OF ASSAYS, KITS, & REAGENTS TO DRIVE THE MARKET GROWTH
TABLE 11 BIOLOGICS SAFETY TESTING CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 12 NORTH AMERICA: BIOLOGICS SAFETY TESTING CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 13 EUROPE: BIOLOGICS SAFETY TESTING CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 14 ASIA PACIFIC: BIOLOGICS SAFETY TESTING CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.4 INSTRUMENTS
6.4.1 THE DEMAND FOR FULLY AUTOMATED INSTRUMENTS IS INCREASING IN RESEARCH APPLICATIONS
TABLE 15 BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 16 NORTH AMERICA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 17 EUROPE: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 18 ASIA PACIFIC: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

7 BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE (Page No. - 65)
7.1 INTRODUCTION
TABLE 19 BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
7.2 RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS
7.2.1 RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
TABLE 20 RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 21 NORTH AMERICA: RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 22 EUROPE: RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 23 ASIA PACIFIC: RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.3 MYCOPLASMA TESTS
7.3.1 GROWING CONCERNS OVER CELL CULTURE CONTAMINATION TO DRIVE MARKET GROWTH
TABLE 24 MYCOPLASMA TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 25 NORTH AMERICA: MYCOPLASMA TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 26 EUROPE: MYCOPLASMA TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 27 ASIA PACIFIC: MYCOPLASMA TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.4 STERILITY TESTS
7.4.1 STERILITY TESTING IS MANDATORY AT EVERY STAGE IN THE DRUG DEVELOPMENT AND PRODUCTION PROCESS
TABLE 28 STERILITY TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 29 NORTH AMERICA: STERILITY TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 30 EUROPE: STERILITY TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 31 ASIA PACIFIC: STERILITY TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.5 ENDOTOXIN TESTS
7.5.1 INCREASING ADOPTION OF ENDOTOXIN TESTING FOR COVID-19 RESEARCH AND DRUG DEVELOPMENT TO FAVOR MARKET GROWTH
TABLE 32 ENDOTOXIN TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 33 NORTH AMERICA: ENDOTOXIN TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 34 EUROPE: ENDOTOXIN TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 35 ASIA PACIFIC: ENDOTOXIN TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.6 VIRUS SAFETY TESTS
7.6.1 HIGHER UPTAKE OF VIRUS SAFETY TESTS IN THE DEVELOPMENT OF VACCINES AND CELL & GENE THERAPY TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 36 VIRUS SAFETY TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 37 NORTH AMERICA: VIRUS SAFETY TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 38 EUROPE: VIRUS SAFETY TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 39 ASIA PACIFIC: VIRUS SAFETY TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.7 BIOBURDEN TESTS
7.7.1 INCREASING FOCUS ON DRUG SAFETY STANDARDS HAS INCREASED THE DEMAND FOR MICROBIOLOGICAL BIOBURDEN TESTING IN THE BIOLOGICS INDUSTRY
TABLE 40 BIOBURDEN TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 41 NORTH AMERICA: BIOBURDEN TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 42 EUROPE: BIOBURDEN TESTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 43 ASIA PACIFIC: BIOBURDEN TESTS MARKET, BY COUNTRY,2019-2026 (USD MILLION)

8 BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION (Page No. - 78)
8.1 INTRODUCTION
TABLE 44 BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
8.2 MONOCLONAL ANTIBODIES MANUFACTURING
8.2.1 MONOCLONAL ANTIBODIES MANUFACTURING IS THE LARGEST APPLICATION SEGMENT
TABLE 45 BIOLOGICS SAFETY TESTING MARKET FOR MONOCLONAL ANTIBODIES MANUFACTURING, BY REGION, 2019-2026 (USD MILLION)
TABLE 46 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET FOR MONOCLONAL ANTIBODIES MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 47 EUROPE: BIOLOGICS SAFETY TESTING MARKET FOR MONOCLONAL ANTIBODIES MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 48 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET FOR MONOCLONAL ANTIBODIES MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
8.3 VACCINES MANUFACTURING
8.3.1 GROWING PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT THE GROWTH OF THIS SEGMENT
TABLE 49 BIOLOGICS SAFETY TESTING MARKET FOR VACCINES MANUFACTURING, BY REGION, 2019-2026 (USD MILLION)
TABLE 50 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET FOR VACCINES MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 51 EUROPE: BIOLOGICS SAFETY TESTING MARKET FOR VACCINES MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 52 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET FOR VACCINES MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
8.4 BLOOD & BLOOD PRODUCTS MANUFACTURING
8.4.1 SAFETY TESTING IS A CRITICAL PARAMETER IN THE REGULATORY APPROVAL FOR BLOOD PRODUCTS
TABLE 53 BIOLOGICS SAFETY TESTING MARKET FOR BLOOD & BLOOD PRODUCTS MANUFACTURING, BY REGION, 2019-2026 (USD MILLION)
TABLE 54 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET FOR BLOOD & BLOOD PRODUCTS MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 55 EUROPE: BIOLOGICS SAFETY TESTING MARKET FOR BLOOD & BLOOD PRODUCTS MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 56 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET FOR BLOOD & BLOOD PRODUCTS MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
8.5 CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING
8.5.1 INCREASING APPROVALS OF CELLULAR AND GENE THERAPY PRODUCTS TO DRIVE MARKET GROWTH
TABLE 57 BIOLOGICS SAFETY TESTING MARKET FOR CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY REGION, 2019-2026 (USD MILLION)
TABLE 58 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET FOR CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 59 EUROPE: BIOLOGICS SAFETY TESTING MARKET FOR CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY COUNTRY,2019-2026 (USD MILLION)
TABLE 60 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET FOR CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY COUNTRY, 2019-2026 (USD MILLION)
8.6 OTHER APPLICATIONS
TABLE 61 BIOLOGICS SAFETY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
TABLE 62 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 63 EUROPE: BIOLOGICS SAFETY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 64 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)

9 BIOLOGICS SAFETY TESTING MARKET, BY REGION (Page No. - 89)
9.1 INTRODUCTION
TABLE 65 BIOLOGICS SAFETY TESTING MARKET, BY REGION, 2019-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET SNAPSHOT
TABLE 66 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 67 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 68 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 69 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American biologics safety testing market
TABLE 70 US: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 71 US: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 72 US: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing biopharmaceutical industry in the country to favor market growth
TABLE 73 CANADA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 74 CANADA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 75 CANADA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.3 EUROPE
TABLE 76 EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 77 EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 78 EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 79 EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Increasing investments in biologics to drive the market in Germany
TABLE 80 GERMANY: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 81 GERMANY: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 82 GERMANY: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Increase in vaccine manufacturing to drive market growth
TABLE 83 UK: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 84 UK: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 85 UK: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Government initiatives to strengthen R&D activities will propel market growth
TABLE 86 FRANCE: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 87 FRANCE: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 88 FRANCE: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Favorable government support to drive market growth in Italy
TABLE 89 ITALY: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION,2019-2026 (USD MILLION)
TABLE 90 ITALY: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 91 ITALY: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increase in biologics production to support market growth
TABLE 92 SPAIN: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 93 SPAIN: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 94 SPAIN: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.3.6 REST OF EUROPE (ROE)
TABLE 95 REST OF EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 96 REST OF EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 97 REST OF EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET SNAPSHOT
TABLE 98 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 99 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 100 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 101 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China is the fastest-growing country for biologics safety testing products and services
TABLE 102 CHINA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 103 CHINA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 104 CHINA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Expansion of biologics manufacturing plants in Japan to support market growth
TABLE 105 JAPAN: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 106 JAPAN: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 107 JAPAN: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growth in the biologics market to dive the adoption of biologics safety testing products and services in India
TABLE 108 BIOLOGICS AND BIOSIMILARS APPROVED IN INDIA, 2014-2019
TABLE 109 INDIA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 110 INDIA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 111 INDIA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 112 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 113 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 114 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 GROWING APPROVAL OF BIOSIMILARS TO SUPPORT MARKET GROWTH
TABLE 115 LATIN AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 116 LATIN AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 117 LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING R&D INVESTMENTS AND THE DEVELOPMENT OF NEW DRUGS ARE KEY FACTORS DRIVING MARKET GROWTH
TABLE 118 MIDDLE EAST & AFRICA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 121)
10.1 OVERVIEW
10.2 MARKET RANKING ANALYSIS
FIGURE 26 BIOLOGICS SAFETY TESTING MARKET RANKING, 2020
10.3 COMPANY EVALUATION MATRIX
10.3.1 STARS
10.3.2 EMERGING LEADERS
10.3.3 PERVASIVE PLAYERS
10.3.4 PARTICIPANTS
FIGURE 27 BIOLOGICS SAFETY TESTING MARKET: COMPANY EVALUATION MATRIX, 2020
10.4 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
10.4.1 PROGRESSIVE COMPANIES
10.4.2 STARTING BLOCKS
10.4.3 DYNAMIC COMPANIES
10.4.4 RESPONSIVE COMPANIES
FIGURE 28 BIOLOGICS SAFETY TESTING: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2020
10.5 MARKET EVALUATION FRAMEWORK
TABLE 121 MARKET EVALUATION FRAMEWORK: EXPANSIONS & PRODUCT LAUNCHES ARE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS
10.6 COMPANY PRODUCT FOOTPRINT
TABLE 122 BIOLOGICS SAFETY TESTING MARKET: PRODUCT PORTFOLIO ANALYSIS
10.7 COMPANY TEST TYPE FOOTPRINT
TABLE 123 BIOLOGICS SAFETY TESTING MARKET: TEST TYPE ANALYSIS
10.8 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 124 BIOLOGICS SAFETY TESTING MARKET: GEOGRAPHIC ANALYSIS
10.9 COMPANY FOOTPRINT
TABLE 125 BIOLOGICS SAFETY TESTING MARKET: COMPANY FOOTPRINT
10.1 COMPETITIVE SCENARIO
10.10.1 BIOLOGICS SAFETY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2018-APRIL 2021
10.10.2 BIOLOGICS SAFETY TESTING MARKET: DEALS, JANUARY 2018-APRIL 2021
10.10.3 BIOLOGICS SAFETY TESTING MARKET: OTHER DEVELOPMENTS,JANUARY 2018-APRIL 2021

11 COMPANY PROFILES (Page No. - 133)
(Business Overview, Products & services offered, Recent Developments, and Right to win)*
11.1 KEY PLAYERS
11.1.1 CHARLES RIVER LABORATORIES, INC.
TABLE 126 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
FIGURE 29 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.2 LONZA
TABLE 127 LONZA: BUSINESS OVERVIEW
FIGURE 30 LONZA: COMPANY SNAPSHOT (2020)
11.1.3 THERMO FISHER SCIENTIFIC, INC.
TABLE 128 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
11.1.4 MERCK KGAA
TABLE 129 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.5 SGS SA
TABLE 130 SGS SA: BUSINESS OVERVIEW
FIGURE 33 SGS SA: COMPANY SNAPSHOT (2020)
11.1.6 EUROFINS SCIENTIFIC
TABLE 131 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 34 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.1.7 WUXI APPTEC
TABLE 132 WUXI APPTEC: BUSINESS OVERVIEW
FIGURE 35 WUXI APPTEC: COMPANY SNAPSHOT (2020)
11.1.8 ASSOCIATES OF CAPE COD, INC.
TABLE 133 ASSOCIATES OF CAPE COD: BUSINESS OVERVIEW
11.1.9 BIOMÉRIEUX SA
TABLE 134 BIOMÉRIEUX SA: BUSINESS OVERVIEW
FIGURE 36 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)
11.1.10 SAMSUNG BIOLOGICS
TABLE 135 SAMSUNG BIOLOGICS: BUSINESS OVERVIEW
FIGURE 37 SAMSUNG BIOLOGICS: COMPANY SNAPSHOT (2020)
11.1.11 GENSCRIPT
TABLE 136 GENSCRIPT: BUSINESS OVERVIEW
FIGURE 38 GENSCRIPT: COMPANY SNAPSHOT (2020)
11.1.12 SARTORIUS AG
TABLE 137 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2020)
11.1.13 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMAN-LA ROCHE LTD.)
TABLE 138 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
11.1.14 PACIFIC BIOLABS
TABLE 139 PACIFIC BIOLABS: BUSINESS OVERVIEW
11.1.15 NELSON LABORATORIES, LLC (A PART OF SOTERA HEALTH)
TABLE 140 NELSON LABORATORIES: BUSINESS OVERVIEW
11.1.16 AGILENT TECHNOLOGIES, INC.
TABLE 141 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
FIGURE 41 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
11.1.17 MARAVAI LIFESCIENCES
TABLE 142 MARAVAI LIFESCIENCES: BUSINESS OVERVIEW
FIGURE 42 MARAVAI LIFESCIENCES: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 QIAGEN
11.2.2 BIO-RAD LABORATORIES, INC.
11.2.3 MICROCOAT BIOTECHNOLOGIE GMBH
11.2.4 INVIVOGEN
11.2.5 PROMOCELL GMBH
11.2.6 ACCUGEN LABORATORIES, INC.
11.2.7 FUJIFILM WAKO PURE CHEMICAL CORPORATION
11.2.8 ALMAC GROUP
*Details on Business Overview, Products & services offered, Recent Developments, and Right to win might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 180)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
COVID-19
Get in-depth analysis of the COVID-19 impact on the Biologics Safety Testing Market